Galderma reports strong nine-month results, raises full-year guidance

Galderma reported net sales of $4.765 billion for the first nine months of 2026, up 25.1% year-on-year on a constant currency basis, and raised its full-year net sales guidance. The company cited continued growth in its dermatology portfolio.

Detected & updated continuously · Source: Nebula